HB 1065

  • Indiana House Bill
  • 2025 Regular Session
  • Introduced in House
  • Passed House Feb 17, 2025
  • Passed Senate Mar 18, 2025
  • Signed by Governor Apr 03, 2025

Cancer clinical trial program.

Votes


Actions


Apr 03, 2025

Office of the Governor

Signed by the Governor

House

Public Law 29

Mar 27, 2025

Senate

Signed by the President of the Senate

Mar 24, 2025

Senate

Signed by the President Pro Tempore

Mar 20, 2025

House

Signed by the Speaker

Mar 19, 2025

Senate

Returned to the House without amendments

Mar 18, 2025

Senate

Third reading: passed; Roll Call 242: yeas 49, nays 0

Senate

Senator Randolph added as cosponsor

Mar 17, 2025

Senate

Second reading: ordered engrossed

Mar 13, 2025

Senate

Committee report: do pass, adopted

Mar 03, 2025

Senate

First reading: referred to Committee on Health and Provider Services

  • Reading-1
  • Referral-Committee
Health and Provider Services

Feb 18, 2025

House

Referred to the Senate

Feb 17, 2025

House

Representatives Barrett, Aylesworth, Porter added as coauthors

House

Cosponsor: Senator Jackson L

House

Senate sponsors: Senators Charbonneau, Crider, Yoder

House

Representative Aylesworth removed as coauthor

House

Third reading: passed; Roll Call 166: yeas 95, nays 0

Feb 13, 2025

House

Second reading: ordered engrossed

Feb 11, 2025

House

Committee report: amend do pass, adopted

Jan 27, 2025

House

Representative Aylesworth added as coauthor

Jan 08, 2025

House

Authored by Representative Shackleford

House

First reading: referred to Committee on Public Health

  • Reading-1
  • Referral-Committee
Public Health

Bill Text

Bill Text Versions Format
Enrolled House Bill (H) PDF
House Bill (H) PDF
House Bill (S) PDF
Introduced House Bill (H) PDF

Related Documents

Document Format
Fiscal Note: HB1065.04.ENRS.FN001 PDF

Sources

Data on Open States is updated periodically throughout the day from the official website of the Indiana General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.